Kiniksa Pharmaceuticals International (KNSA) Cash & Current Investments (2017 - 2026)
Kiniksa Pharmaceuticals International's Cash & Current Investments was $525.93 million in Q2 2026, up 70.9% from $307.78 million a year earlier and up 12.4% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Kiniksa Pharmaceuticals International came in at $414.07 million, up 70.0% from FY2024.
- Cash & Current Investments has now increased for four consecutive years, with a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $243.63 million in FY2024 (+18.1%), $206.37 million in FY2023 (+8.3%), $190.61 million in FY2022 (+4.6%) and $182.2 million in FY2021 (-43.7%).
- The Q2 2026 figure marks the highest quarterly Cash & Current Investments in data going back to Q4 2017.
- Compared with a year earlier, Cash & Current Investments has increased for 16 straight quarters, with growth averaging 46.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2026 (growth of 74.4%); the worst was Q3 2021 (a decline of 45.1%).
- Per Business Quant data, KNSA's Cash & Current Investments in the three quarters before Q2 2026 was $468.09 million (Q1 2026), $414.07 million (Q4 2025) and $352.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 525.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 525.93 Mn |
| Mar 31, 2026 | 468.09 Mn |
| Dec 31, 2025 | 414.07 Mn |
| Sep 30, 2025 | 352.10 Mn |
| Jun 30, 2025 | 307.78 Mn |
| Mar 31, 2025 | 268.34 Mn |
| Dec 31, 2024 | 243.63 Mn |
| Sep 30, 2024 | 223.78 Mn |
| Jun 30, 2024 | 218.76 Mn |
| Mar 31, 2024 | 213.55 Mn |
| Dec 31, 2023 | 206.37 Mn |
| Sep 30, 2023 | 201.08 Mn |
| Jun 30, 2023 | 184.99 Mn |
| Mar 31, 2023 | 187.49 Mn |
| Dec 31, 2022 | 190.61 Mn |
| Sep 30, 2022 | 200.72 Mn |
| Jun 30, 2022 | 138.21 Mn |
| Mar 31, 2022 | 145.58 Mn |
| Dec 31, 2021 | 182.20 Mn |
| Sep 30, 2021 | 200.18 Mn |
API Access
Kiniksa Pharmaceuticals International Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();